Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Workers - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
2.2 mg/m³
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
30
Modified dose descriptor starting point:
NOAEC
Value:
66.1 mg/m³
Explanation for the modification of the dose descriptor starting point:
Inhalation systemic long term. Route-to-route extrapolation: NOECcorr=NOAEL oral*(1/0.38 m³/kg/d)*(ABSorl-rat/ABSinh-human)*(6.7 m³ (8h/10 m³ (8h) 0 75 mg/kg/d*(1/0.38 m³/kg/d)*(0.5*1)*0.67=66.1 mg/m³. It is assumed that oral absorption rate in 50% of that of inhaltion adsorption. ABSoral/rat=oral adsorption rate in rats, ABSinh./human=inhalation absorption rate in humans.
AF for dose response relationship:
1
Justification:
NOAEL was used as starting point
AF for differences in duration of exposure:
6
Justification:
DNEL based on an oral 28-day exposure study in rats
AF for interspecies differences (allometric scaling):
1
Justification:
Already considered during route to route extrapolation.
AF for other interspecies differences:
1
Justification:
Besides the applied allometric scaling factors no additional interspecies factor for remaining differences has been used. In the oral repeated dose study, no specific systemic effects were observed. The primary effect was local irritation. No additional interspecies differences are expected for this effect. In addition rodents like the rat are in general more sensitive compared to human. Anatomical differences as well as air flow patterns between rodents and humans have to be taken into account. Within the ERASM project, studies in rats and mice were being examined. The results suggest that a factor of 2.5 for 'remaining‘ interspecies differences may be questionable as a default value (Escher and Mangelsdorf, 2009; Batke et al, 2011; Bitsch et al, 2006).
AF for intraspecies differences:
5
Justification:
default factor for workers
AF for the quality of the whole database:
1
Justification:
GLP guideline study
AF for remaining uncertainties:
1
Justification:
default factor
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Workers - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
0.625 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
120
Modified dose descriptor starting point:
NOAEL
Value:
75 mg/kg bw/day
Explanation for the modification of the dose descriptor starting point:
Same rate of absorption was assumed after dermal and oral exposure.
AF for dose response relationship:
1
Justification:
NOAEL was used as starting point
AF for differences in duration of exposure:
6
Justification:
DNEL based on an oral 28-day exposure study in rats
AF for interspecies differences (allometric scaling):
4
Justification:
This factor describes the differences in metabolic rate between rats and humans based on body weight and is generally applicable to renally excreted substances.
AF for other interspecies differences:
1
Justification:
Besides the applied allometric scaling factors no additional interspecies factor for remaining differences has been used. In the oral repeated dose study, no specific systemic effects were observed. The primary effect was local irritation. No additional interspecies differences are expected for this effect. In addition rodents like the rat are in general more sensitive compared to human. Anatomical differences as well as air flow patterns between rodents and humans have to be taken into account. Within the ERASM project, studies in rats and mice were being examined. The results suggest that a factor of 2.5 for 'remaining‘ interspecies differences may be questionable as a default value (Escher and Mangelsdorf, 2009; Batke et al, 2011; Bitsch et al, 2006).
AF for intraspecies differences:
5
Justification:
default factor for workers
AF for the quality of the whole database:
1
Justification:
GLP guideline study
AF for remaining uncertainties:
1
Justification:
default factor
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
medium hazard (no threshold derived)
Most sensitive endpoint:
sensitisation (skin)
Acute/short term exposure
Hazard assessment conclusion:
medium hazard (no threshold derived)
Most sensitive endpoint:
sensitisation (skin)

Workers - Hazard for the eyes

Local effects

Hazard assessment conclusion:
no hazard identified

Additional information - workers

General Population - Hazard via inhalation route

Systemic effects

Acute/short term exposure
DNEL related information

Local effects

Acute/short term exposure
DNEL related information

General Population - Hazard via dermal route

Systemic effects

Acute/short term exposure
DNEL related information

General Population - Hazard via oral route

Systemic effects

Acute/short term exposure
DNEL related information

General Population - Hazard for the eyes

Additional information - General Population

As there are no consumer uses, no consumer DNELs were derived.